- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07579182
Hormones, Outcomes, and Pain Pathways in Exercise Study (HOPE)
Mechanical and Non-mechanical Contributions to Chronic Neck, Shoulder, Arm, and Back Pain in Full-busted Women
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Type d'étude
Inscription (Estimé)
Phase
- La phase 1
Contacts et emplacements
Coordonnées de l'étude
- Nom: Stacey L Gorniak, PhD
- Numéro de téléphone: 713-743-4802
- E-mail: sgorniak@uh.edu
Lieux d'étude
-
-
Texas
-
Houston, Texas, États-Unis, 77204
- Recrutement
- University of Houston
-
Contact:
- Stacey L Gorniak, PhD
- Numéro de téléphone: 713-743-4802
- E-mail: sgorniak@uh.edu
-
Chercheur principal:
- Stacey L Gorniak, PhD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Able to provide informed consent
- Age of 18 to 60 years
- Assigned female sex at birth
- Right-handed by self-declaration
- Willing to participate in one online testing session and up to four in-person testing sessions
- Bra band size between 32-40"
- International Physical Activity Questionnaire - Short Form (IPAQ-SF) score of 2 or higher
- An answer of "NO" to any item of the general health questions of the PARQ+
- No history of surgery to the: back, neck, or shoulders or joint replacement
- No history of implanted pacemakers or other stimulation devices
- No history of spinal cord injury (SCI)
Exclusion Criteria:
- Inability to provide informed consent
- Age 17 years old or younger or 61 years or older
- Assigned male sex at birth
- Left-handed by self-declaration
- Not willing to participate in one online testing session and up to four in-person testing sessions
- Bra band size greater than 40" or less than 32"
- IPAQ-SF score of 1 or lower
- An answer of "YES" to any item of the general health questions of the PARQ+
- History of limb amputation (upper or lower extremity)
- Presence of open pressure sores on the upper or lower extremities
- Currently pregnant or lactating/breastfeeding
- History of surgery to the: back, neck, or shoulders or joint replacement
- History of breast cancer and/or mastectomy
- History of implanted pacemakers or other stimulation devices
- History of spinal cord injury (SCI)
- History of joint disease including osteoarthritis and/or Rheumatoid Arthritis
- History of the following neurological diseases: Cerebrovascular accident (CVA, stroke), Alzheimer's Disease (AD), Dementia (of any form), Huntington's Disease, Traumatic Brain Injury (TBI), Spinal cord injury (SCI), Multiple Sclerosis (MS), Parkinson's Disease (PD), Polio, Paraproteinaemic Demyelinating Neuropathy (PDN) and/or Monoclonal Gammopathy of Undetermined Significance (MGUS), Myasthenia Gravis, Muscular Dystrophy, Guillain-Barré Syndrome, Scoliosis, Charcot-Marie-Tooth Disorder or other hereditary neuropathies
Additional Inclusion Criteria for Intervention Group:
a. Self-declared breast size of D-I cup (US sizes: D, E, F, G, H)
Additional Inclusion Criteria for the Control Group:
a. Self-declared breast size of A-C cup (US sizes: AA, A, B, C)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Control
Women with bra cup sizes A - C. Control group will undergo measurement of kinematic and kinetic data during physical activities at baseline.
Study questionnaires, pain measures, body composition, brain activity, and blood-based biomarkers will be collected at baseline.
Physical activity will be tracked via smartwatch for 3 months after baseline.
|
|
|
Expérimental: Interventional Sports Bra
Women with bra cup sizes D - I. Intervention group will undergo measurement of kinematic and kinetic data during physical activities at baseline and 3 months after receiving their interventional sports bras.
Study questionnaires, pain measures, body composition, brain activity, and blood-based biomarkers will be collected at baseline and 3 months after receiving the interventional sports bras.
Physical activity will be tracked via smartwatch for 3 months after baseline.
|
This study involves use of observation and analysis of behavior in assessing breast motion and associated health outcomes while using a provided interventional sports bra of participant choice (Bounceless bra or Shefit Ultimate bra) for 3 months.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pain Measures
Délai: Baseline and 3 months after baseline
|
Qualitative assessment of pain via self-report (no units)
|
Baseline and 3 months after baseline
|
|
Objective Pain Measure
Délai: Baseline and 3 months after baseline
|
Nociceptive Flexion Reflex Threshold (mV)
|
Baseline and 3 months after baseline
|
|
Physical activity
Délai: Baseline and 3 months after baseline
|
Frequency and duration of physical activity as measured via smartwatch
|
Baseline and 3 months after baseline
|
|
Anthropometry
Délai: Baseline and 3 months after baseline
|
Percent body fat (%)
|
Baseline and 3 months after baseline
|
|
Anthropometry
Délai: Baseline and 3 months after baseline
|
Body mass index (BMI) (kg/m²)
|
Baseline and 3 months after baseline
|
|
Glycated Hemoglobin
Délai: Baseline and 3 months after baseline
|
A1c (%)
|
Baseline and 3 months after baseline
|
|
Lipids
Délai: Baseline and 3 months after baseline
|
Total Cholesterol (mg/dL)
|
Baseline and 3 months after baseline
|
|
Lipids
Délai: Baseline and 3 months after baseline
|
High Density Lipoprotein Cholesterol (HDL) (mg/dL)
|
Baseline and 3 months after baseline
|
|
Biomechanical Data
Délai: Baseline and 3 months after baseline
|
Muscle activity (mV)
|
Baseline and 3 months after baseline
|
|
Neuroimaging Data
Délai: Baseline and 3 months after baseline
|
Oxygenated Hemoglobin (HbO) (p-value)
|
Baseline and 3 months after baseline
|
|
Neuroimaging Data
Délai: Baseline and 3 months after baseline
|
Deoxygenated Hemoglobin (HbR) (p-value)
|
Baseline and 3 months after baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Blood Pressure
Délai: Baseline and 3 months after baseline
|
Systole and Diastole (mmHg)
|
Baseline and 3 months after baseline
|
|
Systemic Inflammation Index
Délai: Baseline and 3 months after baseline
|
SII (no units)
|
Baseline and 3 months after baseline
|
|
Neuroimaging Data
Délai: Baseline and 3 months after baseline
|
Total Hemoglobin (HbT) (p-value)
|
Baseline and 3 months after baseline
|
|
Biomechanical Data
Délai: Baseline and 3 months after baseline
|
Breast tissue acceleration (m/s2)
|
Baseline and 3 months after baseline
|
|
Biomechanical Data
Délai: Baseline and 3 months after baseline
|
Gait speed (m/s)
|
Baseline and 3 months after baseline
|
|
Biomechanical Data
Délai: Baseline and 3 months after baseline
|
Cadence (Hz)
|
Baseline and 3 months after baseline
|
|
Menopausal Status
Délai: Baseline
|
Age at menopause (years) - if applicable
|
Baseline
|
|
Sex-Hormones
Délai: Baseline and 3 months after baseline
|
Testosterone (mg/dL)
|
Baseline and 3 months after baseline
|
|
Sex-Hormones
Délai: Baseline and 3 months after baseline
|
Estradiol (mg/dL)
|
Baseline and 3 months after baseline
|
|
Sex-Hormones
Délai: Baseline and 3 months after baseline
|
Progesterone (mg/dL)
|
Baseline and 3 months after baseline
|
|
Sex-Hormones
Délai: Baseline and 3 months after baseline
|
Follicle Stimulating Hormone (mg/dL)
|
Baseline and 3 months after baseline
|
|
Sex-Hormones
Délai: Baseline and 3 months after baseline
|
Sex Hormone Binding Globulin (nmol/L)
|
Baseline and 3 months after baseline
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Stacey L Gorniak, PhD, University of Houston
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- La douleur
- Manifestations neurologiques
- Maladies du système nerveux
- Processus pathologiques
- Conditions pathologiques, signes et symptômes
- Comportement
- Signes et symptômes
- Mal au dos
- Poids
- Inflammation
- Lombalgie
- La douleur du cou
- Douleur thoracique
- Mastodynie
- Manifestations neuromusculaires
- Activité motrice
Autres numéros d'identification d'étude
- STUDY00005233
- R01AR084021-01A1 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
What data outputs will the research generate?
Biomechanical Evaluation Data Blood-based Biomarker Data (e.g., inflammation markers, sex-hormone values) Health State Data (e.g., blood pressure values, BMI, body composition values, menopausal status) Pain Data Physical Activity Data Functional Neuroimaging Data (t-values of Cortical Oxygenated, Deoxygenated, and Total Hemoglobin)
Manuscripts (which will also be publicly available via Pubmed upon publication)
Délai de partage IPD
Critères d'accès au partage IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .